MONOCLONAL ANTI-INTERLEUKIN-2 RECEPTOR ANTIBODY (BT563) PREVENTS EARLY REJECTION AFTER KIDNEY-TRANSPLANTATION - A DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL
T. Vangelder et al., MONOCLONAL ANTI-INTERLEUKIN-2 RECEPTOR ANTIBODY (BT563) PREVENTS EARLY REJECTION AFTER KIDNEY-TRANSPLANTATION - A DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL, Kidney international, 47(2), 1995, pp. 708-708